18 completed. 18 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 18 | Completed 18 |
| Phase 2 | 3 | Completed 3 |
Follow Hemodialysis: new trials by email Literature Review of Hemodialysis trials Research Report on Hemodialysis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of Topical Lidocaine and Benzocaine on Pain Level and Injection Satisfaction Lidocaine Spray: Each ml contained 10 mg lidocaine and ethanol. Applied to the local site to provide anesthesia, Benzocaine spray, Placebo group (control arm) - Pain, Satisfaction | Phase 3 | Completed | TC Erciyes University | 60 | 2024-04-01 | 2025-12-01 |
| Ramipril in Pediatric Patients on Hemodialysis Ramipril, placebo - Hemodialysis | Phase 2 / Phase 3 | Completed | Ain Shams University | 135 | 2018-12-01 | 2020-10-14 |
| A Web Application for Improving Communication on Hemodialysis Rounds Web-App, Paper - Hemodialysis | Phase 3 | Completed | University of Alberta | 77 | 2018-11-28 | 2020-03-25 |
| Comparison of the Human Acellular Vessel (HAV) With Fistulas as Conduits for Hemodialysis Human Acellular Vessel (HAV), Arteriovenous fistula (AVF), Hemodialysis - Renal Failure, End Stage Renal Disease | Phase 3 | Completed | Humacyte, Inc. | 242 | 2017-09-29 | 2025-11-20 |
| Comparison of the Human Acellular Vessel (HAV) With ePTFE Grafts as Conduits for Hemodialysis Human Acellular Vessel (HAV), ePTFE graft - Renal Failure, End Stage Renal Disease | Phase 3 | Completed | Humacyte, Inc. | 355 | 2016-05-24 | 2026-08-19 |
| A Phase III Study of PA21 With Calcium Carbonate in Hemodialysis Patients With Hyperphosphatemia PA21 - Hemodialysis, Hyperphosphatemia | Phase 3 | Completed | Kissei Pharmaceutical Co., Ltd. | 35 | 2013-04-29 | 2018-10-09 |
| A Phase III Study of PA21 in Hemodialysis Patients With Hyperphosphatemia PA21, Sevelamer hydrochloride - Hemodialysis, Hyperphosphatemia | Phase 3 | Completed | Kissei Pharmaceutical Co., Ltd. | 213 | 2013-04-23 | 2018-10-09 |
| Outcome Study of Lanthanum Carbonate Compared With Calcium Carbonate in Hemodialysis Patients : Landmark Study Lanthanum Carbonate, Calcium Carbonate - Hemodialysis, Hyperphosphatemia | Phase 3 | Completed | Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | 2309 | 2011-12-24 | 2020-11-30 |
| Effect of Lowering the Dialysate Sodium on Blood Pressure in Hemodialysis Patients Lowering the dialysate sodium - Hemodialysis | Phase 3 | Completed | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 35 | 2011-11-01 | 2017-11-06 |
| Comparison of Efficacy and Safety of Paricalcitol Injection With Maxacalcitol Injection in Adult Japanese Chronic Kidney Disease Subjects Receiving Hemodialysis With Secondary Hyperparathyroidism paricalcitol, maxacalcitol, paricalcitol placebo - Secondary Hyperparathyroidism, Hemodialysis | Phase 3 | Completed | AbbVie (prior sponsor, Abbott) | 255 | 2011-05-01 | 2013-06-06 |
| Prasugrel Versus High Dose Clopidogrel in Clopidogrel Resistant Patients Undergoing Chronic Hemodialysis Prasugrel, Clopidogrel - Hemodialysis, Chronic Renal Failure | Phase 3 | Completed | University of Patras | 70 | 2010-05-01 | 2010-11-16 |
| HEMOTOL: Efficacy and Safety of Hemodialysis On-line Monitoring Devices on Hemodynamic Stability in Intensive Care Unit Standard Hemodialysis, with Blood Volume Management (BVM®) only, with Blood Volume (BVM®) and Temperature (BTM®) on-line monitoring - Hemodialysis | Phase 2 / Phase 3 | Completed | University Hospital, Caen | 600 | 2008-12-01 | 2010-03-03 |
| GORE VIABAHN Endoprosthesis Versus Percutaneous Transluminal Angioplasty (PTA) to Revise AV Grafts in Hemodialysis GORE VIABAHN Endoprosthesis with PROPATEN Bioactive Surface, Percutaneous Transluminal Angioplasty - Renal Failure, Hemodialysis | Phase 3 | Completed | W.L.Gore & Associates | 293 | 2008-09-01 | 2014-10-21 |
| The Effect of Pomegranate Juice on Oxidative Stress in Hemodialysis Patients Pomegranate juice, Placebo - End Stage Renal Disease, Hemodialysis | Phase 3 | Completed | Western Galilee Hospital-Nahariya | 2008-07-01 | 2010-03-23 | |
| Addition of Heparin to Taurolock-TM CLS in HD Patients With TCC Dose it Improve Catheter Patency Problems ? Catheter Lock Solution Taurolidine and Citrate, Catheter Lock Solution :Taurolidine and Citrate and Heparin, Catheter Lock Solution : Heparin - End Stage Renal Disease, Hemodialysis | Phase 3 | Completed | Western Galilee Hospital-Nahariya | 2007-05-01 | 2008-09-09 | |
| The Efficacy of Melatonin in Sleep Problems of Hemodialysis and Peritoneal Dialysis Patients Melatonin - Hemodialysis, Peritoneal Dialysis | Phase 3 | Completed | Meander Medical Center | 40 | 2005-04-01 | 2008-01-29 |
| A Comparison of Dalteparin and Tinzaparin for Prevention of Blood Clots in Hemodialysis Patients on Oral Anticoagulants Having Surgery Fragmin (dalteparin), Innohep (tinzaparin) - Thromboembolism, Hemodialysis | Phase 2 / Phase 3 | Completed | Ottawa Hospital Research Institute | 29 | 2003-10-01 | 2014-09-10 |
| Hemocontrol and Blood Pressure Control in Dialysis Patients Hemocontrol Biofeedback System - End-Stage Renal Disease, Hemodialysis | Phase 3 | Completed | Université de Montréal | 60 | 2002-12-01 | 2006-04-27 |
Kidney Failure, Chronic (7) · Hyperphosphatemia (3) · Renal Insufficiency (3) · Hypotension (2) · Acute Kidney Injury (1) · Arteriovenous Fistula (1) · Chronic Kidney Disease-Mineral and Bone Disorder (1) · Edema (1) · Hyperparathyroidism, Secondary (1) · Hypertension (1) · Pain (1) · Parasomnias (1) · Personal Satisfaction (1) · Thromboembolism (1) · Vascular Calcification (1)
Female Urogenital Diseases (10) · Female Urogenital Diseases and Pregnancy Complications (10) · Kidney Diseases (10) · Male Urogenital Diseases (10) · Urogenital Diseases (10) · Urologic Diseases (10) · Pathological Conditions, Signs and Symptoms (9) · Chronic Disease (8) · Disease Attributes (8) · Pathologic Processes (8) · Renal Insufficiency, Chronic (7) · Renal Insufficiency (6) · Cardiovascular Diseases (4) · Vascular Diseases (4) · Metabolic Diseases (3)
Angioplasty (1) · Arteriovenous Shunt, Surgical (1) · Calcium Carbonate (1) · Citric Acid (1) · Clopidogrel (1) · Dalteparin (1) · Heparin (1) · Lidocaine (1) · Melatonin (1) · Paper (1) · Prasugrel Hydrochloride (1) · Ramipril (1) · Renal Dialysis (1) · Sevelamer (1) · Social Control, Formal (1)
Humacyte, Inc. (2) · Kissei Pharmaceutical Co., Ltd. (2) · Western Galilee Hospital-Nahariya (2) · AbbVie (prior sponsor, Abbott) (1) · Ain Shams University (1) · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (1) · Meander Medical Center (1) · Ottawa Hospital Research Institute (1) · TC Erciyes University (1) · Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan (1) · University Hospital, Caen (1) · University of Alberta (1) · University of Patras (1) · Université de Montréal (1) · W.L.Gore & Associates (1)
Canada (4) · Japan (4) · Israel (3) · United States (3) · Egypt (1) · France (1) · Germany (1) · Greece (1) · Netherlands (1) · Poland (1) · Portugal (1) · Turkey (Türkiye) (1) · United Kingdom (1)
Shamik Parikh, MD (2) · Francois Madore, MD (1) · Kazuya Kobayashi, BA (1) · Marc Rodger, MD, MSc (1) · Piet ter Wee, MD, PhD (1) · Rita Suri, MD, MSc (1) · Stephanie Thompson, MD PhD (1) · Tadao Akizawa, MD, PhD (1) · Tom Vesely, MD (1)
PMID 39498822, PMID 40576086, PMID 19076157, PMID 22535635, PMID 24593225, PMID 30717951, PMID 34003226, PMID 34377501, PMID 35224730, PMID 35686561, PMID 37662589, PMID 38189593, PMID 42613284
2015 (1)